Frankfurt am Main, March 9, 2006 - Nanostart AG has sold two of its listed US investments. The company has made a profitable sale of its shareholdings in Arrowhead Research, Corp., Pasadena, and Integral Vision, Inc. from Farmington Hills. As a result of these sales, the Frankfurt-based nanotechnology investment company has generated overall profits in the treble percentage region.

In the first months following its foundation, Nanostart AG had already invested in Arrowhead Research and Integral Vision. The revenues of the sales will be invested for the most part in new, non-listed nanotechnology companies in Europe and the USA.

About Nanostart AG:
Nanostart AG is a listed nanotechnology investment company whose activities are divided into two areas: one of its focuses is investing in fast-growing nanotechnology companies; its other key area of activity is advising companies in the financial industry on investments in the nanotechnology sector.

Disclaimer:
This notification represents neither an offer to sell nor an invitation to submit an offer to buy or subscribe securities. The admission of the shares of Nanostart AG in the sub-segment of the Open Market of the Frankfurt Stock Exchange, the Entry Standard, does not constitute a public offer of securities. This notification does not represent a securities prospectus. This notification and the information contained therein is not intended to be passed on, whether directly or indirectly, to or within the United States of America, Canada, Australia or Japan.

Media contact:
Nanostart AG
Public Relations
Dr. Hans Joachim Dürr
Goethestrasse 26-28
60313 Frankfurt
Germany
phone: +49 (0)69-21 93 96 111
fax:     +49 (0)69-21 93 96 122
e-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it